Margetuximab Biosimilar
REQUEST MORE INFO
Catalogue No: abx831290
Price:
US$435.00
(Size: 100 µg)
Orders to United States ship from United States
Add to Cart
Buy It Now
GET A QUOTE
Documents
Datasheet SDS
Margetuximab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ERBB2/EGFR2/CD340, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Margetuximab is under investigation in clinical trial NCT03133988 (Margetuximab Expanded Access Program).
Research Articles on ERBB2/EGFR2/CD340
| Target | ERBB2/EGFR2/CD340 |
| Research Area | Chimeric Monoclonal Antibodies, Biosimilars |
| Clonality | Monoclonal |
| Reactivity | Human |
| Expression | Recombinant |
| Tested Applications | ELISA |
| Host | Human, Mouse |
| Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Isotype | IgG1 Kappa |
| Form | Liquid |
| Purity | > 95% |
| Purification | Purified from cell culture supernatants by Protein A/G chromatography. |
| Storage | Store at 4°C for up to 2 weeks. Aliquot and store at -20°C for long term storage. Avoid repeated freeze/thaw cycles. |
| Shelf Life | 12 months. |
| Buffer | 0.01 M PBS, pH 7.4. |
| CAS Number | 1350624-75-7 |
| Concentration | Batch-dependent, typically between 0.5-2.0 mg/ml. |
| Availability | Shipped within 5-10 working days. |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |
